LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Appoints Erica Raether as Vice President of People, Culture and ESG
July 20, 2021 07:00 ET | Recro Pharma, Inc.
EXTON, Pa., July 20, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
22157.jpg
Pharmaceutical Contract Manufacturing Industry M&A Implications and Outlook Report 2021: Objectives, M&A Activity 2018-2020, Target Characteristics, Acquirer Characteristics, Geography, Top Acquirers
July 16, 2021 07:48 ET | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition" report has been...
22157.jpg
Global Pharmaceutical Contract Manufacturing Market Report 2021: Market to Reach $130.2 Billion by 2026 - API/Bulk Drugs Segments is Projected to Account for $81.5 Billion
July 15, 2021 07:23 ET | Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
22157.jpg
Global and China CDMO Market 2021-2025 - The Rise of Domestic Innovative Drugs Brings Incremental Space
July 13, 2021 07:38 ET | Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Global and China CDMO (Contract Development and Manufacturing Organization) Market Insight Report, 2021-2025" report has been added to...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Enters Development and Manufacturing Agreement With New Client
July 13, 2021 07:00 ET | Recro Pharma, Inc.
GAINESVILLE, Ga., July 13, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports Inducement Grants for New Staff
July 07, 2021 07:00 ET | Recro Pharma, Inc.
EXTON, Pa., July 07, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
AGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings
July 01, 2021 12:00 ET | AGC Biologics
Seattle, July 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the signing of a purchase agreement...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of Directors
July 01, 2021 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments
June 29, 2021 16:05 ET | Avid Bioservices, Inc
-- Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million -- -- Achieved Four Consecutive Quarters of Operational Profitability During Fiscal 2021 -- -- Signed...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, 2021
June 22, 2021 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...